TITLE

COMMENTARY: Review: Bisphosphonates prevent or delay skeletal events in women with advance breast cancer and bone metastases

AUTHOR(S)
O'Regan, Ruth
PUB. DATE
March 2006
SOURCE
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p39
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents a study which reveals that Bisphosphonates prevent or delay skeletal events in women with advance breast cancer and bone metastases. Bisphosphonates have a wide spectrum of uses in breast cancer. Researchers reviewed the use of bisphosphonates in 3 specific breast cancer related situations. The researchers noted that the use of bisphosphonates in patients with bone metastases definitely reduces the rate of skeletal-related events (SREs). Zoledronate, the most potent bisphosphonate currently available, is at least as effective as pamidronate in preventing SREs and has a much-reduced infusion time.
ACCESSION #
20297599

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics